日付	保有者名	取引株数	金額レンジ ($)	取引種別	価格レンジ ($)	届出終了時の株数	% 変化
2026-05-28	Dr. Robert B. HuizingaInterim CEO, Director & Member of Scientific Advisory Board	4.00M	0.00	Derivative Acquisition Under Employee Benefit Plan	0.04	4.00M	-
2026-06-02	Ms. Lori ChristofalosChief Quality Officer	1.50M	0.00	Derivative Acquisition Under Employee Benefit Plan	0.04	1.50M	-
2026-05-28	Mr. Shameze RampertabDirector	500.00k	0.00	Derivative Acquisition Under Employee Benefit Plan	0.04	500.00k	-
2025-03-11	Mr. Ray DupuisCFO	-62.50k	0.00	Other Derivative Disposition	0.07	0.00	-100.00%
2026-05-28	Mr. Ray DupuisCFO	1.75M	0.00	Derivative Acquisition Under Employee Benefit Plan	0.04	1.75M	-
2026-05-28	Dr. David M. KideckelDirector	1,000.00k	0.00	Derivative Acquisition Under Employee Benefit Plan	0.04	1,000.00k	-
2026-05-25	Mr. Philip R. RenaudChairman	20.00M	724.56k	買い	0.04	70.39M	39.69%
2025-12-17	Mr. Philip R. RenaudChairman	14.00M	507.89k	買い	0.04	50.39M	38.47%
2025-05-09	Dr. Robert B. HuizingaInterim CEO, Director & Member of Scientific Advisory Board	-1.75M	0.00	Other Derivative Disposition	-	550.00k	-76.09%

Hot Features

Kane Biotech Inc (PK) (KNBIF)